Organising Committee (OC)

Fabio Candotti
Fabio Candotti is Full Professor of Medicine at the University of Lausanne and Head Physician in the Division of Immunology and Allergy of the Lausanne University Hospital, in Lausanne, Switzerland. He received his MD from the University of Brescia (Italy) and completed his residencies in Paediatrics and Paediatric Allergy and Immunology at the Universities of Pavia (Italy), and Brescia (Italy), before joining the National Institutes of Health in the USA as a postdoc in the field of gene therapy.
From 1998 to 2014, Prof Candotti headed the Disorders of Immunity Section of the National Human Genome Research Institute of NIH where he focused his clinical and research activities on primary immunodeficiencies (PIDs), with particular interest on the Wiskott-Aldrich syndrome and adenosine deaminase deficiency. In 2014, he was recruited by the University Hospital of Lausanne, where he currently heads the clinical Unit on PIDs of the Division of Immunology and Allergy.
Prof Candotti has published 190 indexed articles and 60 reviews and book chapters on PIDs and gene therapy. He currently serves as President of the European Society for Immunodeficiency, Associate Editor of Paediatric Allergy and Immunology, and Specialty Chief Editor of the Primary Immunodeficiencies section of Frontiers.